See All Slides - tctmd.com

Slides

Presentation TCT 2012

Stent Selection in STEMI: Critical Review of the Data

Presenter: Peter Smits

October 22, 2012

Presentation TCT 2012

The Appropriate Use Criteria: Genesis, Application, and Next Steps

Presenter: Thomas Maloney

October 22, 2012

Presentation TCT 2012

Debate I. Is a Strategy of Endovascular Thrombus Resolution Best for Iliofemoral DVT? Con!

Presenter: Erich Minar

October 22, 2012

Presentation TCT 2012

A Prospective, Randomized Trial of N-Acetyl Cysteine and Sodium Bicarbonate in Patients with ST-Segment Elevation Myocardial Infarction

Presenter: Lisette Okkels Jensen

October 22, 2012

Presentation TCT 2012

Case 5: An “Impossible” Case I Succeeded That Changed My View of CTO PCI

Presenter: Toshiya Muramatsu

October 22, 2012

Presentation TCT 2012

Branch or Embolize? Managing Iliac Aneurysms Involving the Hypogastrics

Presenter: James McKinsey

October 22, 2012

Presentation TCT 2012

Personalized Medicine: Current Tools and the Future of Clinical Research in Practice

Presenter: David Cohen

October 22, 2012

Presentation TCT 2012

Debate I. Is Embolic Protection Mandatory in Renal Artery Stenting? Con!

Presenter: Christopher Cooper

October 22, 2012

Presentation TCT 2012

Restenosis After Coronary Stenting in 10,004 Patients with Follow-up Angiography

Presenter: Salvatore Cassese

October 22, 2012

Presentation TCT 2012

Approach to the Case with Limited/No Antegrade Options

Presenter: Tony DeMartini

October 22, 2012

Advertisement

Slides

Stent Selection in STEMI: Critical Review of the Data

The Appropriate Use Criteria: Genesis, Application, and Next Steps

Debate I. Is a Strategy of Endovascular Thrombus Resolution Best for Iliofemoral DVT? Con!

A Prospective, Randomized Trial of N-Acetyl Cysteine and Sodium Bicarbonate in Patients with ST-Segment Elevation Myocardial Infarction

Case 5: An “Impossible” Case I Succeeded That Changed My View of CTO PCI

Branch or Embolize? Managing Iliac Aneurysms Involving the Hypogastrics

Personalized Medicine: Current Tools and the Future of Clinical Research in Practice

Debate I. Is Embolic Protection Mandatory in Renal Artery Stenting? Con!

Restenosis After Coronary Stenting in 10,004 Patients with Follow-up Angiography

Approach to the Case with Limited/No Antegrade Options

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content